medigraphic.com
ISSN 0016-3813 (Print)

2018, Number S1

<< Back Next >>

Gac Med Mex 2018; 154 (S1)

Dose in continuous renal replacement therapy

Claure-Del Granado R

Language: English
References: 52
Page: 40-47
PDF size: 229.81 Kb.


ABSTRACT

Continuous renal replacement therapy (CRRT) is one of the most used types of renal replacement therapies for the treatment of critically ill patients with acute kidney injury (AKI). Recent practice clinical guidelines based on recent clinical trials recommend a prescribed dose of 20-25 mL/kg/h of effluent since these trials could not find differences between high-intensity versus low-intensity CRRT dose and different outcomes as mortality and recovery of renal function. Nevertheless, the results of these recent trials do not mean that CRRT dose is not important, and on the contrary, these trials inform us that dose needs to be continuously assessed and modified according to clinical, metabolic, and physiological needs of each patient. Dose prescription in CRRT needs to be a dynamic and precise process, in which evidence-based quality measures will be used to guide CRRT dose prescription that will match daily patients needs. Delivered dose should be routinely monitored to ensure that it will be achieved. Quality measures for monitoring delivered dose of CRRT have been proposed, but they still need validation, before be implemented into clinical practice.


REFERENCES

  1. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26-30.

  2. Neri M, Villa G, Garzotto F, et al. Nomenclature for renal replacement therapy in acute kidney injury: basic principles. Crit Care. 2016;20:318.

  3. Copyright and License Information. Section 5: dialysis Interventions for Treatment of AKI. Kidney Int Suppl (2011). 2012;2:89-115.

  4. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7-20.

  5. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627-38.

  6. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346:305-10.

  7. Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006;70:1312-7.

  8. Tolwani AJ, Campbell RC, Stofan BS, et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008; 19:1233-8.

  9. Vesconi S, Cruz DN, Fumagalli R, et al. Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care. 2009;13:R57.

  10. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205-11.

  11. Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision continuous renal replacement therapy and solute control. Blood Purif. 2016;42:238-47.

  12. Claure-Del Granado R, Mehta RL. Assessing and delivering dialysis dose in acute kidney injury. Semin Dial. 2011;24:157-63.

  13. Ricci Z, Salvatori G, Bonello M, et al. In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care. 2005;9:R266-73.

  14. Davenport A, Bouman C, Kirpalani A, et al. Delivery of renal replacement therapy in acute kidney injury: what are the key issues? Clin J Am Soc Nephrol. 2008;3:869-75.

  15. Marshall MR. Current status of dosing and quantification of acute renal replacement therapy. Part 1: mechanisms and consequences of therapy under-delivery. Nephrology (Carlton). 2006;11:171-80.

  16. Davenport A, Farrington K. Dialysis dose in acute kidney injury and chronic dialysis. Lancet. 2010;375:705-6.

  17. Goldstein SL, Currier H, Graf CD, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001;107:1309-12.

  18. Gillespie RS, Seidel K, Symons JM. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol. 2004;19:1394-9.

  19. Foland JA, Fortenberry JD, Warshaw BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32:1771-6.

  20. Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12:R74.

  21. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422-7.

  22. Sutherland SM, Zappitelli M, Alexander SR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010;55:316-25.

  23. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the national cooperative dialysis study. N Engl J Med. 1981;305:1176-81.

  24. Parker TF 3rd, Husni L, Huang W, Lew N, Lowrie EG. Survival of hemodialysis patients in the united states is improved with a greater quantity of dialysis. Am J Kidney Dis. 1994;23:670-80.

  25. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis. 1994;23:661-9.

  26. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50:550-6.

  27. Joannes-Boyau O, Honoré PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med. 2013;39:1535-46.

  28. Park JT, Lee H, Kee YK, et al. High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis. 2016;68:599-608.

  29. Fayad AI, Buamscha DG, Ciapponi A. Intensity of continuous renal replacement therapy for acute kidney injury. Cochrane Database Syst Rev. 2016;10:CD010613.

  30. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the united states. J Crit Care. 2002;17:246-50.

  31. Claure-Del Granado R, Macedo E, Chertow GM, et al. Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clin J Am Soc Nephrol. 2011;6:467-75.

  32. Paganini EP. Dialysis is not dialysis is not dialysis! Acute dialysis is different and needs help! Am J Kidney Dis. 1998;32:832-3.

  33. Kanagasundaram NS, Greene T, Larive AB, et al. Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure. Kidney Int. 2003;64:2298-310.

  34. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis. 2002;39:556-70.

  35. Himmelfarb J, Evanson J, Hakim RM, et al. Urea volume of distribution exceeds total body water in patients with acute renal failure. Kidney Int. 2002;61:317-23.

  36. Carson RC, Kiaii M, MacRae JM. Urea clearance in dysfunctional catheters is improved by reversing the line position despite increased access recirculation. Am J Kidney Dis. 2005;45:883-90.

  37. Leblanc M, Fedak S, Mokris G, Paganini EP. Blood recirculation in temporary central catheters for acute hemodialysis. Clin Nephrol. 1996;45:315-9.

  38. Little MA, Conlon PJ, Walshe JJ. Access recirculation in temporary hemodialysis catheters as measured by the saline dilution technique. Am J Kidney Dis. 2000;36:1135-9.

  39. Oliver MJ, Edwards LJ, Treleaven DJ, Lambert K, Margetts PJ. Randomized study of temporary hemodialysis catheters. Int J Artif Organs. 2002;25:40-4.

  40. Level C, Lasseur C, Chauveau P, et al. Performance of twin central venous catheters: influence of the inversion of inlet and outlet on recirculation. Blood Purif. 2002;20:182-8.

  41. Klouche K, Amigues L, Deleuze S, Beraud JJ, Canaud B. Complications, effects on dialysis dose, and survival of tunneled femoral dialysis catheters in acute renal failure. Am J Kidney Dis. 2007;49:99-108.

  42. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med. 2003;29:575-8.

  43. Feldhoff P, Turnham T, Klein E. Effect of plasma proteins on the sieving spectra of hemofilters. Artif Organs. 1984;8:186-92.

  44. Macedo E, Claure-Del Granado R, Mehta RL. Effluent volume and dialysis dose in CRRT: time for reappraisal. Nat Rev Nephrol. 2011;8 57-60.

  45. Jaffrin MY. Convective mass transfer in hemodialysis. Artif Organs. 1995;19:1162-71.

  46. Garred L, Leblanc M, Canaud B. Urea kinetic modeling for CRRT. Am J Kidney Dis. 1997;30 5 Suppl 4:S2-9.

  47. Fall P, Szerlip HM. Continuous renal replacement therapy: cause and treatment of electrolyte complications. Semin Dial. 2010;23:581-5.

  48. Morimatsu H, Uchino S, Bellomo R, Ronco C. Continuous renal replacement therapy: does technique influence electrolyte and bicarbonate control? Int J Artif Organs. 2003;26:289-96.

  49. Lewis SJ, Mueller BA. Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent. Semin Dial. 2014;27:441-5.

  50. Lewis SJ, Mueller BA. Antibiotic dosing in patients with acute kidney injury: “enough but not too much”. J Intensive Care Med. 2016;31:164-76.

  51. Wooley JA, Btaiche IF, Good KL. Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract. 2005;20:176-91.

  52. Honoré PM, De Waele E, Jacobs R, et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif. 2013;35:279-84.




2020     |     www.medigraphic.com